Prediabetes – References

Andrew P. Koutnik

Current: Principal Investigator & Research Faculty Institute for Sports Science and Medicine Department of Health, Nutrition, and Food Sciences College of Education, Health, and Human Sciences Florida State University; Visiting Research Scientist Human Healthspan, Resilience, and Performance Florida Institute for Human and Machine Cognition

Past: Principal Investigator, Research Scientist, Samsun Diabetes Research Institute, Principal Investigator, Research Scientist, Human Healthspan, Resilience and Performance, Florida Institute for Human and Machine Cognition, Presidential Fellow, University of South Florida Morsani College of Medicine, Department of Molecular Pharmacology & Physiology, Honor Medallion and Bess Ward Honor Awardee, Florida State University; Department of Biomedical Sciences, College of Medicine; Department of Exercise Science, College of Health and Human Sciences, Affiliate, Help a Diabetes Help a Diabetic Child. Research and Therapeutic Outreach.

Dr. Andrew P. Koutnik, Ph.D. is an award-winning research scientist recognized for his leadership in diabetes and chronic disease research

References

Prediabetes – References

  1. Inoue K, Liu M, Aggarwal R, Marinacci LX, Wadhera RK. Prevalence and Control of Diabetes Among US Adults, 2013 to 2023. JAMA 2025.
  2. In: Cowie CC, Casagrande SS, Menke A, et al., eds. Diabetes in America. 3rd ed. Bethesda (MD); 2018.
  3. Echouffo-Tcheugui JB, Selvin E. Prediabetes and What It Means: The Epidemiological Evidence. Annu Rev Public Health 2021; 42: 59-77.
  4. Andes LJ, Cheng YJ, Rolka DB, Gregg EW, Imperatore G. Prevalence of Prediabetes Among Adolescents and Young Adults in the United States, 2005-2016. JAMA Pediatr 2020; 174(2): e194498.
  5. Han C, Song Q, Ren Y, Chen X, Jiang X, Hu D. Global prevalence of prediabetes in children and adolescents: A systematic review and meta-analysis. J Diabetes 2022; 14(7): 434-41.
  6. Prevention CfDCa. National Diabetes Statistics Report. Atlanta, GA; 2022.
  7. Shilo S, Keshet A, Rossman H, et al. Continuous glucose monitoring and intrapersonal variability in fasting glucose. Nat Med 2024; 30(5): 1424-31.
  8. Prins PJ, Noakes TD, Buga A, et al. Low and High Carbohydrate Isocaloric Diets on Performance, Fat Oxidation, Glucose and Cardiometabolic Health in Middle Age Athletes. Front Nutr 2023.
  9. Noakes TD, D’Agostino DP, Volek JS, Prins PJ, Koutnik AP. The effect of the low-carbohydrate high-fat (LCHF) diet on the crossover point during exercise of increasing intensity. Front Physiology 2023.
  10. Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev 2013; 93(1): 137-88.
  11. Ferrannini E, Gastaldelli A, Iozzo P. Pathophysiology of prediabetes. Med Clin North Am 2011; 95(2): 327-39, vii-viii.
  12. Abdul-Ghani MA, DeFronzo RA. Pathophysiology of prediabetes. Curr Diab Rep 2009; 9(3): 193-9.
  13. Dybjer E, Nilsson PM, Engstrom G, Helmer C, Nagga K. Pre-diabetes and diabetes are independently associated with adverse cognitive test results: a cross-sectional, population-based study. BMC Endocr Disord 2018; 18(1): 91.
  14. Schlesinger S, Neuenschwander M, Barbaresko J, et al. Prediabetes and risk of mortality, diabetes-related complications and comorbidities: umbrella review of meta-analyses of prospective studies. Diabetologia 2022; 65(2): 275-85.
  15. Chaytor NS, Barbosa-Leiker C, Ryan CM, Germine LT, Hirsch IB, Weinstock RS. Clinically significant cognitive impairment in older adults with type 1 diabetes. J Diabetes Complications 2019; 33(1): 91-7.
  16. Mazaika PK, Weinzimer SA, Mauras N, et al. Variations in Brain Volume and Growth in Young Children With Type 1 Diabetes. Diabetes 2016; 65(2): 476-85.
  17. Nunley KA, Rosano C, Ryan CM, et al. Clinically Relevant Cognitive Impairment in Middle-Aged Adults With Childhood-Onset Type 1 Diabetes. Diabetes Care 2015; 38(9): 1768-76.
  18. Marzelli MJ, Mazaika PK, Barnea-Goraly N, et al. Neuroanatomical correlates of dysglycemia in young children with type 1 diabetes. Diabetes 2014; 63(1): 343-53.
  19. Barnea-Goraly N, Raman M, Mazaika P, et al. Alterations in white matter structure in young children with type 1 diabetes. Diabetes Care 2014; 37(2): 332-40.
  20. Tonoli C, Heyman E, Roelands B, et al. Type 1 diabetes-associated cognitive decline: a meta-analysis and update of the current literature. J Diabetes 2014; 6(6): 499-513.
  21. Watso JC, Robinson AT, Singar SAB, Cuba JN, Koutnik AP. Advanced Cardiovascular Physiology in an Individual with Type 1 Diabetes After 10-Year Ketogenic Diet. Am J Physiol Cell Physiol 2024.
  22. Ng HY, Chan LTW. Prediabetes in children and adolescents: An updated review. World J Clin Pediatr 2023; 12(5): 263-72.
  23. Nwosu BU. The Progression of Prediabetes to Type 2 Diabetes in Children and Adolescents in the United States: Current Challenges and Solutions. Endocrines 2022; 3(3): 545-51.
  24. Organization WH. Obesity and overweight, 2025.
  25. Gupta A, Choudhary N, Gupta N. Prediabetes in children and adolescents: A ticking bomb! World J Clin Pediatr 2024; 13(2): 92127.
  26. Mittal M, Jethwani P, Naik D, Garg MK. Non-medicalization of medical science: Rationalization for future. World J Methodol 2022; 12(5): 402-13.
  27. Brodersen J, Schwartz LM, Heneghan C, O’Sullivan JW, Aronson JK, Woloshin S. Overdiagnosis: what it is and what it isn’t. BMJ Evid Based Med 2018; 23(1): 1-3.
  28. Zhang H, Guo Y, Hua G, et al. Exercise training modalities in prediabetes: a systematic review and network meta-analysis. Front Endocrinol (Lausanne) 2024; 15: 1308959.
  29. Buchanan L, Calkins M, Kalayjian T, et al. TOWARD, a metabolic health intervention, demonstrates robust 1-year weight loss and cost-savings through deprescription. Front Nutr 2025; 12: 1548609.
  30. Oser TK, Cucuzzella M, Stasinopoulos M, Moncrief M, McCall A, Cox DJ. An Innovative, Paradigm-Shifting Lifestyle Intervention to Reduce Glucose Excursions With the Use of Continuous Glucose Monitoring to Educate, Motivate, and Activate Adults With Newly Diagnosed Type 2 Diabetes: Pilot Feasibility Study. JMIR Diabetes 2022; 7(1): e34465.
  31. Dorans KS, Bazzano LA, Qi L, et al. Effects of a Low-Carbohydrate Dietary Intervention on Hemoglobin A1c: A Randomized Clinical Trial. JAMA Netw Open 2022; 5(10): e2238645.
  32. McKenzie AL, Athinarayanan SJ. Impact of Glucagon-Like Peptide 1 Agonist Deprescription in Type 2 Diabetes in a Real-World Setting: A Propensity Score Matched Cohort Study. Diabetes Ther 2024; 15(4): 843-53.
  33. McKenzie AL, Athinarayanan SJ, Van Tieghem MR, et al. 5-Year effects of a novel continuous remote care model with carbohydrate-restricted nutrition therapy including nutritional ketosis in type 2 diabetes: An extension study. Diabetes Res Clin Pract 2024; 217: 111898.
  34. Koutnik AP, Klein S, Robinson AT, Watso JC. Efficacy and Safety of Long-term Ketogenic Diet Therapy in a Patient With Type 1 Diabetes. JCEM Case Rep 2024; 2(7): luae102.
  35. KOUTNIK AP, WOOD T, STOROSCHUK K, LENNERZ BS. 608-P: Carbohydrate Intake, Glycemic Control, and Cardiometabolic Risk Factors in Type 1 Diabetes—A Systematic Review and Meta-regression. Diabetes 2024; 73(Supplement_1).
  36. Evert AB, Dennison M, Gardner CD, et al. Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report. Diabetes Care 2019; 42(5): 731-54.
  37. Agriculture USDo, Services USDoHaH. Dietary Guidelines for Americans, 2020-2025. 9th ed; 2025.
  38. Volek JS, Yancy WS, Jr., Gower BA, et al. Expert consensus on nutrition and lower-carbohydrate diets: An evidence- and equity-based approach to dietary guidance. Front Nutr 2024; 11: 1376098.

Related topics